GLORIA IHEUWA: Open Payments
NPI 1104690072 · BROCKTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,072 in 125 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $1,058 · 2025 $3,072
Food & beverage: $2,756Education: $300Consulting: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 31 | $849 |
| Novartis Pharmaceuticals Corporation | 22 | $368 |
| Regeneron Healthcare Solutions, Inc. | 9 | $324 |
| GlaxoSmithKline, LLC. | 11 | $270 |
| Grifols USA, LLC | 9 | $219 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $176 |
| Amgen Inc. | 5 | $118 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $101 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Genentech USA, Inc. | 4 | $90 |
Products named: DUPIXENT, AIRSUPRA, TEZSPIRE, NUCALA, FASENRA, Prolastin-C Liquid, Rhapsido, BREZTRI.
Industry payments across MA — which companies pay providers there.
